0
Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol
Jeffrey A. Lieberman, M.D.; Gary Tollefson, M.D., Ph.D.; Mauricio Tohen, M.D., Dr.P.H.; Alan I. Green, M.D.; Raquel E. Gur, M.D., Ph.D.; Rene Kahn, M.D., Ph.D.; Joseph McEvoy, M.D.; Diana Perkins, M.D., M.P.H.; Tonmoy Sharma, M.D.; Robert Zipursky, M.D.; Hank Wei, Ph.D.; Robert M. Hamer, Ph.D.; the HGDH Study Group
Maintenance Treatment of Schizophrenia With Risperidone or Haloperidol: 2-Year Outcomes
Stephen R. Marder, M.D.; Shirley M. Glynn, Ph.D.; William C. Wirshing, M.D.; Donna A. Wirshing, M.D.; Doreen Ross; Clifford Widmark, M.D.; Jim Mintz, Ph.D.; Robert P. Liberman, M.D.; Karen E. Blair, M.S.
Is Regionally Selective D2/D3 Dopamine Occupancy Sufficient for Atypical Antipsychotic Effect? An In Vivo Quantitative [123I]Epidepride SPET Study of Amisulpride-Treated Patients
Rodrigo A. Bressan, M.D., Ph.D.; Kjell Erlandsson, Ph.D.; Hugh M. Jones, M.R.C.Psych.; Rachel Mulligan, B.Sc., M.Sc., Ph.D.; Robert J. Flanagan, B.Sc., Ph.D., F.R.S.C., F.R.C.Path.; Peter J. Ell, M.D., Ph.D., F.R.C.P., M.R.C.R., F.Med.Sci.; Lyn S. Pilowsky, M.R.C.Psych., Ph.D.
The Relationship of Clozapine and Haloperidol Treatment Response to Prefrontal, Hippocampal, and Caudate Brain Volumes
Celso Arango, M.D.; Alan Breier, M.D.; Robert McMahon, Ph.D.; William T. Carpenter, Jr., M.D.; Robert W. Buchanan, M.D.
Transfer of Olanzapine Into Breast Milk, Calculation of Infant Drug Dose, and Effect on Breast-Fed Infants
Sharon J. Gardiner, M.Clin.Pharm.; Judith H. Kristensen, B.Pharm.; Evan J. Begg, M.D.; L. Peter Hackett, M.R.S.C.; Debbie A. Wilson, F.R.A.N.Z.C.P.; Kenneth F. Ilett, Ph.D.; Rolland Kohan, M.B.B.S.; Jonathan Rampono, F.R.A.N.Z.C.P.
Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia?
Steven E. Bruce, Ph.D.; Russell G. Vasile, M.D.; Robert M. Goisman, M.D.; Carl Salzman, M.D.; Megan Spencer, B.S.; Jason T. Machan, Ph.D.; Martin B. Keller, M.D.
Enhanced Salience and Emotion Recognition in Autism: A PET Study
Geoffrey B.C. Hall, Ph.D.; Henry Szechtman, Ph.D.; Claude Nahmias, Ph.D.
Proton Magnetic Resonance Spectroscopy of Bipolar Disorder Versus Intermittent Explosive Disorder in Children and Adolescents
Pablo Davanzo, M.D.; Kenneth Yue, B.S.; M. Albert Thomas, Ph.D.; Thomas Belin, Ph.D.; Jim Mintz, Ph.D.; T.N. Venkatraman, Ph.D.; Eliana Santoro, M.D.; Sarah Barnett, B.A.; James McCracken, M.D.
Discriminative Validity and Clinical Utility of an Abuse-Neglect Interview for Adolescents With Conduct and Substance Use Problems
Thomas J. Crowley, M.D.; Susan K. Mikulich, Ph.D.; Kristen M. Ehlers, B.A.; Shannon K. Hall, B.A.; Elizabeth A. Whitmore, Ph.D.
Early Risk Factors for Violence in Colombian Adolescents
David W. Brook, M.D.; Judith S. Brook, Ed.D.; Zohn Rosen, M.S.; Mario De la Rosa, Ph.D.; Ivan D. Montoya, M.D., M.P.H.; Martin Whiteman, Ph.D.
Comparisons of Problems Reported by Youths From Seven Countries
Frank C. Verhulst, M.D.; Thomas M. Achenbach, Ph.D.; Jan van der Ende, M.S.; Nese Erol, Ph.D.; Michael C. Lambert, Ph.D.; Patrick W.L. Leung, Ph.D.; Maria A. Silva, M.D.; Nelly Zilber, Dr. ès Sc.; Stephen R. Zubrick, B.Sc. M.Sc., A.M., Ph.D.
Peripubertal Suicide Attempts in Offspring of Suicide Attempters With Siblings Concordant for Suicidal Behavior
David A. Brent, M.D.; Maria Oquendo, M.D.; Boris Birmaher, M.D.; Laurence Greenhill, M.D.; David Kolko, Ph.D.; Barbara Stanley, Ph.D.; Jamie Zelazny, B.S.N.; Beth Brodsky, Ph.D.; Sekip Firinciogullari, M.A., M.S.; Steven P. Ellis, Ph.D.; J. John Mann, M.D.
Comorbidity of Axis I and Axis II Disorders in Patients Who Attempted Suicide
Keith Hawton, D.Sc., F.R.C.Psych.; Kelly Houston, B.A.; Camilla Haw, M.R.C.Psych., M.R.C.P.; Ellen Townsend, Ph.D.; Louise Harriss, M.Sc.
Deliberate Self-Harm in a Nonclinical Population: Prevalence and Psychological Correlates
E. David Klonsky, M.A.; Thomas F. Oltmanns, Ph.D.; Eric Turkheimer, Ph.D.
Psychopathology and Comorbidity of Psychiatric Disorders in Patients With Kleptomania
Franck J. Baylé, M.D.; Hervé Caci, M.D., Ph.D.; Bruno Millet, M.D., Ph.D.; Sami Richa, M.D.; Jean-Pierre Olié, M.D.
Clozapine as a First Treatment for Schizophrenia
Margaret G. Woerner, Ph.D.; Delbert G. Robinson, M.D.; Jose Ma. J. Alvir, Dr.P.H.; Brian B. Sheitman, M.D.; Jeffrey A. Lieberman, M.D.; John M. Kane, M.D.
Untreated Depression and Hippocampal Volume Loss
Yvette I. Sheline, M.D.; Mokhtar H. Gado, M.D.; Helena C. Kraemer, Ph.D.
Short-Term Use of Estradiol for Depression in Perimenopausal and Postmenopausal Women: A Preliminary Report
Lee S. Cohen, M.D.; Claudio N. Soares, M.D., Ph.D.; Jennifer R. Poitras, B.A.; Jennifer Prouty, M.S.N., R.N.C.; Allison B. Alexander, M.D.; Jan L. Shifren, M.D.
Increase in Prefrontal Cortex Serotonin2A Receptors Following Estrogen Treatment in Postmenopausal Women
Akira Kugaya, M.D., Ph.D.; C. Neill Epperson, M.D.; Sami Zoghbi, Ph.D.; Christopher H. van Dyck, M.D.; Yankun Hou, Ph.D.; Masahiro Fujita, M.D., Ph.D.; Julie K. Staley, Ph.D.; Pradeep K. Garg, Ph.D.; John P. Seibyl, M.D.; Robert B. Innis, M.D., Ph.D.
Family History of Suicide Among Suicide Victims
Bo Runeson, M.D., Ph.D.; Marie Åsberg, M.D., Ph.D.
Pinday
Richard G. Druss, M.D.